| __timestamp | Bausch Health Companies Inc. | Grifols, S.A. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 180753000 |
| Thursday, January 1, 2015 | 582800000 | 224193000 |
| Friday, January 1, 2016 | 455000000 | 197617000 |
| Sunday, January 1, 2017 | 366000000 | 288320000 |
| Monday, January 1, 2018 | 414000000 | 240661000 |
| Tuesday, January 1, 2019 | 471000000 | 276018000 |
| Wednesday, January 1, 2020 | 452000000 | 294216000 |
| Friday, January 1, 2021 | 465000000 | 354881000 |
| Saturday, January 1, 2022 | 529000000 | 361140000 |
| Sunday, January 1, 2023 | 604000000 | 330551000 |
Data in motion
In the ever-evolving pharmaceutical industry, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bausch Health Companies Inc. and Grifols, S.A. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Bausch Health's R&D expenses surged by approximately 145%, peaking in 2023. This reflects a robust commitment to innovation, likely driven by the need to diversify and enhance their product portfolio. In contrast, Grifols, S.A. exhibited a steadier growth, with a 83% increase over the same period, indicating a more consistent approach to R&D. Notably, in 2021, Grifols' R&D expenses reached their zenith, marking a pivotal year for the company. These trends underscore the dynamic nature of R&D investments and their critical role in shaping the future of healthcare.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Research and Development Investment: Jazz Pharmaceuticals plc vs Grifols, S.A.
Blueprint Medicines Corporation or Grifols, S.A.: Who Invests More in Innovation?
Pharming Group N.V. or Grifols, S.A.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Grifols, S.A. vs Opthea Limited
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and Corcept Therapeutics Incorporated
Research and Development Investment: Grifols, S.A. vs HUTCHMED (China) Limited
Grifols, S.A. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Grifols, S.A. and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated